Gardasil Clears FDA, But Dosing May Pose Administrative Challenges
Executive Summary
Administration of Merck's recently approved human papillomavirus vaccine Gardasil at the recommended schedule of zero, two and six months may pose a logistical challenge to vaccinating adolescents